ACHIEVEMENTS & AWARDS
We've reached a few milestones in our journey. We're pretty proud of what we've achieved along the way.
1998
AFT Pharmaceuticals is founded in Auckland, New Zealand.
2005
Offices are opened in Australia.
2011
North Shore Business Awards: Winner of the Westpac Supreme Business Excellence Award and Winner of the Ministry of Science and Innovation Excellence in Design, Research & Development Award.
2012
Maxigesic, a world-first combination analgesic, invented and subsequently licensed to 42 countries.
The novel SURF technology to design the company’s revolutionary hand held nebuliser is licensed.
2013
AFT Pharmaceuticals is granted Early Point Project (EPP) status for an orphan drug manufacturing and export hub based in Malaysia.
Offices are opened in Malaysia, and a branch office in Singapore.
Callaghan Innovation (New Zealand government agency) awards AFT Pharmaceuticals a Technology Development Grant to assist with R&D expenditure up to $3.85M (2013)
2014
Discovery of major formulation error in global cold and flu products published in the New England Journal of Medicine.
Capital Royalty (US) and Milford Asset Management (NZ) collectively invested US$12M in equity into Pharmaceuticals.
Maxigesic is registered in Europe.
2015
A pivotal clinical study in the USA and NZ is completed that forms the basis of AFT’s first filing with the United States Food and Drug Administration.
2017
Maxigesic became licensed in 124 countries worldwide
2018
AFT Pharmaceuticals made the top 1000 fast-growing companies list in the Asia-Pacific region.
What We Do
We develop innovative products that help people. We do this by looking at peoples’ healthcare needs, understanding how needs are changing, and how we can provide treatment options that work.
Discover
Who We Are
Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products and AFT Pharmaceuticals was born. In Australasia, our product line now extends to over 55 products.
Discover
Professional Confirmation
Please confirm your email and profession to access the professional product information & downloads. AFT Pharmaceuticals will not share this information externally.
Licensee Login
Please confirm your email and password to access the licensee product information and downloads. AFT Pharmaceuticals will not share this information externally.
Forgot your password?
Important Notice
AFT Pharmaceuticals Ltd has become aware of an email spam which may contain malware or be an attempt to obtain personal information of recipients. AFT Pharmaceuticals Ltd does not request payment of invoices through email. It is important that you do not click on any links or images contained within the email.
Should you receive this type of email, please delete it immediately, add the sender to a spam or junk emailing list and run anti-virus software. Should you have any concerns please contact AFT. It appears only Australian email addresses are targeted by this spam, as such as have reported its identification to the Australian Competition and Consumer Commission’s Scamwatch. Should you have any concerns please contact Scamwatch (https://www.scamwatch.gov.au/get-help) or AFT Pharmaceuticals Ltd.
As we become aware of developments we will update this notice accordingly. Thank you for your attention and cooperation on this matter.